May 20, 2020 / 1:12 PM / 5 days ago

BRIEF-Cansino Biologics, Precision Nanosystems To Co-Develop COVID-19 RNA Vaccine

May 20 (Reuters) - Cansino Biologics Inc:

* CANSINO BIOLOGICS AND PRECISION NANOSYSTEMS ANNOUNCE COLLABORATION TO CO-DEVELOP A COVID-19 RNA VACCINE

* CANSINO BIOLOGICS - AGREEMENT INCLUDES UNDISCLOSED PAYMENTS AND ROYALTIES

* CANSINO BIOLOGICS - HAS RIGHTS TO COMMERCIALIZE VACCINE PRODUCT IN ASIA (EXCEPT JAPAN) WITH PNI RETAINING RIGHTS FOR REST OF WORLD. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below